NLM Logo

ertumaxomab MeSH Supplementary Concept Data 2025


MeSH Supplementary
ertumaxomab
Unique ID
C511895
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C511895
Registry Numbers
L5L45YGP1O
Heading Mapped to
*Antibodies, Monoclonal
Frequency
9
Note
trifunctional anti-HER2 x anti-CD3 antibody for treatment of metastatic breast cancer; in Phase I trial (5/2006)
Source
Clin Cancer Res 2006 May 15;12(10):3085-91
Indexing Information
Antibodies, Bispecific
Date of Entry
2006/07/20
Revision Date
2019/10/31
ertumaxomab Preferred
page delivered in 0.008s